All Stories

  1. MSJ 2020 – Editorial comment

    Article • Multiple Sclerosis Journal, February 2020, SAGE Publications

    Alan Thompson

  2. MSJ 2019 - Editorial comment

    Article • Multiple Sclerosis Journal, January 2019, SAGE Publications

    Alan Thompson

  3. 2018 Editors’ commentary

    Article • Multiple Sclerosis Journal, October 2018, SAGE Publications

    Alan Thompson

  4. MSJ 2018—editorial comment

    Article • Multiple Sclerosis Journal, February 2018, SAGE Publications

    Alan Thompson

  5. Commentary on the ECTRIMS–EAN guideline for pharmacological treatment of multiple sclerosis

    Article • Therapeutic Advances in Neurological Disorders, January 2018, SAGE Publications

    Alan Thompson

  6. Advancing trial design in progressive multiple sclerosis

    Article • Multiple Sclerosis Journal, October 2017, SAGE Publications

    Alan Thompson

  7. Editorial

    Article • Multiple Sclerosis Journal, June 2017, SAGE Publications

    Alan Thompson

  8. When are we going to take modifiable risk factors more seriously in multiple sclerosis?

    Article • Multiple Sclerosis Journal, April 2017, SAGE Publications

    Alan Thompson

  9. Editorial 2017

    Article • Multiple Sclerosis Journal, January 2017, SAGE Publications

    Alan Thompson

  10. Editorial 2016

    Article • Multiple Sclerosis Journal, December 2015, SAGE Publications

    Alan Thompson